Clinical trial
EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer
NCT00004258 · Indiana University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00004258 |
|---|---|
| Title | EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer |
| Official title | A Phase I Trial of EMD 121974 in Patients With Advanced or Metastatic Cancer |
| Lead sponsor | Indiana University School of Medicine, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous/Nonmalignant Condition, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | cilengitide |
| Enrollment | 40 |
| Start date | Dec 1, 1999 |
| Primary completion | Aug 1, 2001 |
| Completion | Sep 1, 2001 |
| First posted | Jul 26, 2004 |
| Last update posted | Sep 17, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: